---
title: "MBX Biosciences, Inc. (MBX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MBX.US.md"
symbol: "MBX.US"
name: "MBX Biosciences, Inc."
industry: "Pharmaceuticals"
---

# MBX Biosciences, Inc. (MBX.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [mbxbio.com](https://mbxbio.com) |

## Company Profile

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinic...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -18.16 | 202/257 | - | - | - |
| PB | 3.77 | 123/257 | 3.70 | 2.07 | 1.46 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-20T05:00:00.000Z

Total Analysts: **11**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 8 | 73% |
| Overweight | 2 | 18% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 1 | 9% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 32.55 |
| Highest Target | 88.00 |
| Lowest Target | 18.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/MBX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MBX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MBX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.